Robert Glanzman, Chief Medical Officer NewsSeptember 5, 2023245Views0Likes0CommentsBoard-certified neurologist and Fellow of the American Academy of Neurology with over 20 years experience…Read More
Dr. Jack Antel joins our clinical advisory board NewsMay 1, 2023281Views0Likes0CommentsDr. Antel is an internationally acclaimed clinical neurologist and thought leader who coordinates the multiple sclerosis research and treatment …Read More
Formation of a clinical advisory board NewsNovember 7, 2022253Views0Likes0CommentsThe clinical advisory board will guide the company in the development of its autoimmune programs in demyelinating diseases …Read More
Paul F. Truex Nominated Chairman of the Board NewsAugust 1, 2022193Views0Likes0CommentsFind Therapeutics Inc., a biopharmaceutical company, today announced the appointment of Paul F. Truex …Read More
Agreement to Develop a Promising New Therapy NewsJune 7, 2022608Views0Likes0CommentsSATT1 Conectus and Find Therapeutics Sign Licensing Agreement to Develop a Promising New Therapy for Multiple SclerosisRead More
Philippe Douville Appointed Chief Executive Officer NewsFebruary 14, 2022567Views0Likes0CommentsWe are pleased to announce accomplished biotechnology executive and entrepreneur, Dr. Philippe Douville as its new Chief Executive …Read More
Find Therapeutics launches in Montreal NewsJune 8, 2020602Views0Likes0CommentsFind Therapeutics, a new drug development company dedicated to breakthrough therapies against rare diseases launches in Montreal…Read More